Jason N. Butler
Stock Analyst at Citizens
(3.13)
# 1,147
Out of 5,141 analysts
12
Total ratings
50%
Success rate
4.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Reiterates: Market Outperform | $34 | $23.99 | +41.73% | 2 | Feb 3, 2026 | |
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $4.27 | +344.96% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $29.76 | +168.82% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $15.01 | +46.57% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $3.29 | +416.72% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $130.35 | -12.54% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $7.03 | +212.94% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $67.94 | +14.81% | 1 | Sep 2, 2025 | |
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $4.38 | +82.65% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $8.80 | +104.55% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $70.98 | +9.89% | 1 | Aug 6, 2025 |
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Market Outperform
Price Target: $34
Current: $23.99
Upside: +41.73%
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $4.27
Upside: +344.96%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $29.76
Upside: +168.82%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $15.01
Upside: +46.57%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $3.29
Upside: +416.72%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $130.35
Upside: -12.54%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $7.03
Upside: +212.94%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $67.94
Upside: +14.81%
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $4.38
Upside: +82.65%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $8.80
Upside: +104.55%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $70.98
Upside: +9.89%